- Home
- VNRX vs GEG Comparison
VNRX vs GEG Comparison
Compare VNRX & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- GEG
- Stock Information
- Founded
- VNRX N/A
- GEG 1994
- Country
- VNRX United States
- GEG United States
- Employees
- VNRX N/A
- GEG N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GEG Computer Software: Prepackaged Software
- Sector
- VNRX Health Care
- GEG Technology
- Exchange
- VNRX Nasdaq
- GEG Nasdaq
- Market Cap
- VNRX 69.7M
- GEG 72.4M
- IPO Year
- VNRX N/A
- GEG N/A
- Fundamental
- Price
- VNRX $0.39
- GEG $2.45
- Analyst Decision
- VNRX Strong Buy
- GEG
- Analyst Count
- VNRX 4
- GEG 0
- Target Price
- VNRX $3.50
- GEG N/A
- AVG Volume (30 Days)
- VNRX 1.1M
- GEG 12.8K
- Earning Date
- VNRX 11-14-2025
- GEG 11-11-2025
- Dividend Yield
- VNRX N/A
- GEG N/A
- EPS Growth
- VNRX N/A
- GEG N/A
- EPS
- VNRX N/A
- GEG 0.38
- Revenue
- VNRX $1,319,252.00
- GEG $16,315,999.00
- Revenue This Year
- VNRX $324.32
- GEG N/A
- Revenue Next Year
- VNRX $247.82
- GEG N/A
- P/E Ratio
- VNRX N/A
- GEG $6.44
- Revenue Growth
- VNRX 35.10
- GEG N/A
- 52 Week Low
- VNRX $0.39
- GEG $1.70
- 52 Week High
- VNRX $0.94
- GEG $3.51
- Technical
- Relative Strength Index (RSI)
- VNRX 29.55
- GEG 45.36
- Support Level
- VNRX $0.42
- GEG $2.45
- Resistance Level
- VNRX $0.48
- GEG $2.48
- Average True Range (ATR)
- VNRX 0.04
- GEG 0.07
- MACD
- VNRX 0.00
- GEG -0.00
- Stochastic Oscillator
- VNRX 2.22
- GEG 18.67
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.